nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—CYP1A2—Pentoxifylline—systemic scleroderma	0.0751	0.159	CbGbCtD
Citalopram—CYP1A2—Leflunomide—systemic scleroderma	0.0716	0.151	CbGbCtD
Citalopram—ABCB1—Lisinopril—systemic scleroderma	0.0656	0.139	CbGbCtD
Citalopram—ABCB1—Captopril—systemic scleroderma	0.0491	0.104	CbGbCtD
Citalopram—CYP2D6—Captopril—systemic scleroderma	0.0463	0.0979	CbGbCtD
Citalopram—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0387	0.0818	CbGbCtD
Citalopram—CYP2C19—Prednisone—systemic scleroderma	0.0383	0.0811	CbGbCtD
Citalopram—ABCB1—Prednisone—systemic scleroderma	0.0309	0.0654	CbGbCtD
Citalopram—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0232	0.049	CbGbCtD
Citalopram—CYP3A4—Prednisone—systemic scleroderma	0.0185	0.0392	CbGbCtD
Citalopram—ABCB1—Methotrexate—systemic scleroderma	0.0155	0.0328	CbGbCtD
Citalopram—Hypersensitivity—Azathioprine—systemic scleroderma	0.00012	0.000228	CcSEcCtD
Citalopram—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00012	0.000228	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00012	0.000228	CcSEcCtD
Citalopram—Insomnia—Lisinopril—systemic scleroderma	0.00012	0.000228	CcSEcCtD
Citalopram—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00012	0.000227	CcSEcCtD
Citalopram—Paraesthesia—Lisinopril—systemic scleroderma	0.000119	0.000226	CcSEcCtD
Citalopram—Vomiting—Captopril—systemic scleroderma	0.000119	0.000226	CcSEcCtD
Citalopram—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000119	0.000225	CcSEcCtD
Citalopram—Dyspnoea—Lisinopril—systemic scleroderma	0.000118	0.000224	CcSEcCtD
Citalopram—Rash—Captopril—systemic scleroderma	0.000118	0.000224	CcSEcCtD
Citalopram—Dermatitis—Captopril—systemic scleroderma	0.000118	0.000224	CcSEcCtD
Citalopram—Somnolence—Lisinopril—systemic scleroderma	0.000118	0.000224	CcSEcCtD
Citalopram—Headache—Captopril—systemic scleroderma	0.000117	0.000223	CcSEcCtD
Citalopram—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000117	0.000222	CcSEcCtD
Citalopram—Dyspepsia—Lisinopril—systemic scleroderma	0.000117	0.000222	CcSEcCtD
Citalopram—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000116	0.000221	CcSEcCtD
Citalopram—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000116	0.000221	CcSEcCtD
Citalopram—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000116	0.00022	CcSEcCtD
Citalopram—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000116	0.00022	CcSEcCtD
Citalopram—Asthma—Methotrexate—systemic scleroderma	0.000116	0.00022	CcSEcCtD
Citalopram—Infection—Mycophenolate mofetil—systemic scleroderma	0.000115	0.000219	CcSEcCtD
Citalopram—Decreased appetite—Lisinopril—systemic scleroderma	0.000115	0.000219	CcSEcCtD
Citalopram—Eosinophilia—Methotrexate—systemic scleroderma	0.000115	0.000217	CcSEcCtD
Citalopram—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000115	0.000217	CcSEcCtD
Citalopram—Fatigue—Lisinopril—systemic scleroderma	0.000114	0.000217	CcSEcCtD
Citalopram—Shock—Mycophenolate mofetil—systemic scleroderma	0.000114	0.000217	CcSEcCtD
Citalopram—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000114	0.000216	CcSEcCtD
Citalopram—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000114	0.000216	CcSEcCtD
Citalopram—Hypersensitivity—Leflunomide—systemic scleroderma	0.000114	0.000216	CcSEcCtD
Citalopram—Pancreatitis—Methotrexate—systemic scleroderma	0.000114	0.000215	CcSEcCtD
Citalopram—Pain—Lisinopril—systemic scleroderma	0.000113	0.000215	CcSEcCtD
Citalopram—Constipation—Lisinopril—systemic scleroderma	0.000113	0.000215	CcSEcCtD
Citalopram—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000113	0.000215	CcSEcCtD
Citalopram—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000113	0.000214	CcSEcCtD
Citalopram—Bradycardia—Prednisone—systemic scleroderma	0.000113	0.000214	CcSEcCtD
Citalopram—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000112	0.000213	CcSEcCtD
Citalopram—Diarrhoea—Azathioprine—systemic scleroderma	0.000112	0.000212	CcSEcCtD
Citalopram—Haemoglobin—Prednisone—systemic scleroderma	0.000111	0.000211	CcSEcCtD
Citalopram—Nausea—Captopril—systemic scleroderma	0.000111	0.000211	CcSEcCtD
Citalopram—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000111	0.000211	CcSEcCtD
Citalopram—Haemorrhage—Prednisone—systemic scleroderma	0.000111	0.00021	CcSEcCtD
Citalopram—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000111	0.00021	CcSEcCtD
Citalopram—Asthenia—Leflunomide—systemic scleroderma	0.000111	0.00021	CcSEcCtD
Citalopram—Hallucination—Prednisone—systemic scleroderma	0.00011	0.000209	CcSEcCtD
Citalopram—Pancytopenia—Methotrexate—systemic scleroderma	0.00011	0.000209	CcSEcCtD
Citalopram—Feeling abnormal—Lisinopril—systemic scleroderma	0.000109	0.000207	CcSEcCtD
Citalopram—Pruritus—Leflunomide—systemic scleroderma	0.000109	0.000207	CcSEcCtD
Citalopram—Connective tissue disorder—Prednisone—systemic scleroderma	0.000109	0.000207	CcSEcCtD
Citalopram—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000109	0.000206	CcSEcCtD
Citalopram—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000108	0.000206	CcSEcCtD
Citalopram—Dysuria—Methotrexate—systemic scleroderma	0.000108	0.000205	CcSEcCtD
Citalopram—Dizziness—Azathioprine—systemic scleroderma	0.000108	0.000205	CcSEcCtD
Citalopram—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000108	0.000204	CcSEcCtD
Citalopram—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000107	0.000202	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000106	0.000201	CcSEcCtD
Citalopram—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000106	0.0002	CcSEcCtD
Citalopram—Asthenia—Mycophenolic acid—systemic scleroderma	0.000106	0.0002	CcSEcCtD
Citalopram—Diarrhoea—Leflunomide—systemic scleroderma	0.000106	0.0002	CcSEcCtD
Citalopram—Urticaria—Lisinopril—systemic scleroderma	0.000105	0.0002	CcSEcCtD
Citalopram—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000105	0.000199	CcSEcCtD
Citalopram—Abdominal pain—Lisinopril—systemic scleroderma	0.000105	0.000199	CcSEcCtD
Citalopram—Body temperature increased—Lisinopril—systemic scleroderma	0.000105	0.000199	CcSEcCtD
Citalopram—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000104	0.000198	CcSEcCtD
Citalopram—Pruritus—Mycophenolic acid—systemic scleroderma	0.000104	0.000198	CcSEcCtD
Citalopram—Vomiting—Azathioprine—systemic scleroderma	0.000104	0.000197	CcSEcCtD
Citalopram—Pneumonia—Methotrexate—systemic scleroderma	0.000104	0.000197	CcSEcCtD
Citalopram—Eye disorder—Prednisone—systemic scleroderma	0.000104	0.000197	CcSEcCtD
Citalopram—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000104	0.000197	CcSEcCtD
Citalopram—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000196	CcSEcCtD
Citalopram—Infestation NOS—Methotrexate—systemic scleroderma	0.000103	0.000196	CcSEcCtD
Citalopram—Infestation—Methotrexate—systemic scleroderma	0.000103	0.000196	CcSEcCtD
Citalopram—Rash—Azathioprine—systemic scleroderma	0.000103	0.000196	CcSEcCtD
Citalopram—Dermatitis—Azathioprine—systemic scleroderma	0.000103	0.000195	CcSEcCtD
Citalopram—Depression—Methotrexate—systemic scleroderma	0.000103	0.000195	CcSEcCtD
Citalopram—Flushing—Prednisone—systemic scleroderma	0.000103	0.000195	CcSEcCtD
Citalopram—Headache—Azathioprine—systemic scleroderma	0.000102	0.000194	CcSEcCtD
Citalopram—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000102	0.000194	CcSEcCtD
Citalopram—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000102	0.000194	CcSEcCtD
Citalopram—Dizziness—Leflunomide—systemic scleroderma	0.000102	0.000194	CcSEcCtD
Citalopram—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000101	0.000192	CcSEcCtD
Citalopram—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000101	0.000191	CcSEcCtD
Citalopram—Stomatitis—Methotrexate—systemic scleroderma	0.000101	0.000191	CcSEcCtD
Citalopram—Angiopathy—Prednisone—systemic scleroderma	0.000101	0.000191	CcSEcCtD
Citalopram—Conjunctivitis—Methotrexate—systemic scleroderma	0.0001	0.00019	CcSEcCtD
Citalopram—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.0001	0.00019	CcSEcCtD
Citalopram—Immune system disorder—Prednisone—systemic scleroderma	0.0001	0.00019	CcSEcCtD
Citalopram—Pain—Mycophenolate mofetil—systemic scleroderma	9.94e-05	0.000189	CcSEcCtD
Citalopram—Constipation—Mycophenolate mofetil—systemic scleroderma	9.94e-05	0.000189	CcSEcCtD
Citalopram—Arrhythmia—Prednisone—systemic scleroderma	9.91e-05	0.000188	CcSEcCtD
Citalopram—Sweating—Methotrexate—systemic scleroderma	9.9e-05	0.000188	CcSEcCtD
Citalopram—Haematuria—Methotrexate—systemic scleroderma	9.84e-05	0.000187	CcSEcCtD
Citalopram—Vomiting—Leflunomide—systemic scleroderma	9.81e-05	0.000186	CcSEcCtD
Citalopram—Alopecia—Prednisone—systemic scleroderma	9.8e-05	0.000186	CcSEcCtD
Citalopram—Hypersensitivity—Lisinopril—systemic scleroderma	9.77e-05	0.000185	CcSEcCtD
Citalopram—Hepatobiliary disease—Methotrexate—systemic scleroderma	9.76e-05	0.000185	CcSEcCtD
Citalopram—Dizziness—Mycophenolic acid—systemic scleroderma	9.74e-05	0.000185	CcSEcCtD
Citalopram—Epistaxis—Methotrexate—systemic scleroderma	9.74e-05	0.000185	CcSEcCtD
Citalopram—Rash—Leflunomide—systemic scleroderma	9.73e-05	0.000185	CcSEcCtD
Citalopram—Dermatitis—Leflunomide—systemic scleroderma	9.72e-05	0.000184	CcSEcCtD
Citalopram—Mental disorder—Prednisone—systemic scleroderma	9.71e-05	0.000184	CcSEcCtD
Citalopram—Nausea—Azathioprine—systemic scleroderma	9.71e-05	0.000184	CcSEcCtD
Citalopram—Headache—Leflunomide—systemic scleroderma	9.67e-05	0.000183	CcSEcCtD
Citalopram—Malnutrition—Prednisone—systemic scleroderma	9.65e-05	0.000183	CcSEcCtD
Citalopram—Erythema—Prednisone—systemic scleroderma	9.65e-05	0.000183	CcSEcCtD
Citalopram—Agranulocytosis—Methotrexate—systemic scleroderma	9.63e-05	0.000183	CcSEcCtD
Citalopram—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	9.58e-05	0.000182	CcSEcCtD
Citalopram—Asthenia—Lisinopril—systemic scleroderma	9.52e-05	0.000181	CcSEcCtD
Citalopram—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	9.5e-05	0.00018	CcSEcCtD
Citalopram—Pruritus—Lisinopril—systemic scleroderma	9.38e-05	0.000178	CcSEcCtD
Citalopram—Vomiting—Mycophenolic acid—systemic scleroderma	9.36e-05	0.000178	CcSEcCtD
Citalopram—Haemoglobin—Methotrexate—systemic scleroderma	9.31e-05	0.000177	CcSEcCtD
Citalopram—Rash—Mycophenolic acid—systemic scleroderma	9.29e-05	0.000176	CcSEcCtD
Citalopram—Dermatitis—Mycophenolic acid—systemic scleroderma	9.28e-05	0.000176	CcSEcCtD
Citalopram—Hepatitis—Methotrexate—systemic scleroderma	9.27e-05	0.000176	CcSEcCtD
Citalopram—Haemorrhage—Methotrexate—systemic scleroderma	9.27e-05	0.000176	CcSEcCtD
Citalopram—Urticaria—Mycophenolate mofetil—systemic scleroderma	9.23e-05	0.000175	CcSEcCtD
Citalopram—Headache—Mycophenolic acid—systemic scleroderma	9.23e-05	0.000175	CcSEcCtD
Citalopram—Pharyngitis—Methotrexate—systemic scleroderma	9.2e-05	0.000174	CcSEcCtD
Citalopram—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	9.19e-05	0.000174	CcSEcCtD
Citalopram—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	9.19e-05	0.000174	CcSEcCtD
Citalopram—Nausea—Leflunomide—systemic scleroderma	9.17e-05	0.000174	CcSEcCtD
Citalopram—Urinary tract disorder—Methotrexate—systemic scleroderma	9.15e-05	0.000174	CcSEcCtD
Citalopram—Vision blurred—Prednisone—systemic scleroderma	9.1e-05	0.000173	CcSEcCtD
Citalopram—Urethral disorder—Methotrexate—systemic scleroderma	9.08e-05	0.000172	CcSEcCtD
Citalopram—Diarrhoea—Lisinopril—systemic scleroderma	9.08e-05	0.000172	CcSEcCtD
Citalopram—Ill-defined disorder—Prednisone—systemic scleroderma	8.96e-05	0.00017	CcSEcCtD
Citalopram—Visual impairment—Methotrexate—systemic scleroderma	8.93e-05	0.000169	CcSEcCtD
Citalopram—Anaemia—Prednisone—systemic scleroderma	8.92e-05	0.000169	CcSEcCtD
Citalopram—Agitation—Prednisone—systemic scleroderma	8.87e-05	0.000168	CcSEcCtD
Citalopram—Angioedema—Prednisone—systemic scleroderma	8.82e-05	0.000167	CcSEcCtD
Citalopram—Dizziness—Lisinopril—systemic scleroderma	8.77e-05	0.000166	CcSEcCtD
Citalopram—Erythema multiforme—Methotrexate—systemic scleroderma	8.76e-05	0.000166	CcSEcCtD
Citalopram—Nausea—Mycophenolic acid—systemic scleroderma	8.75e-05	0.000166	CcSEcCtD
Citalopram—Malaise—Prednisone—systemic scleroderma	8.7e-05	0.000165	CcSEcCtD
Citalopram—Vertigo—Prednisone—systemic scleroderma	8.67e-05	0.000165	CcSEcCtD
Citalopram—Eye disorder—Methotrexate—systemic scleroderma	8.66e-05	0.000164	CcSEcCtD
Citalopram—Syncope—Prednisone—systemic scleroderma	8.66e-05	0.000164	CcSEcCtD
Citalopram—Tinnitus—Methotrexate—systemic scleroderma	8.64e-05	0.000164	CcSEcCtD
Citalopram—Cardiac disorder—Methotrexate—systemic scleroderma	8.6e-05	0.000163	CcSEcCtD
Citalopram—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	8.56e-05	0.000162	CcSEcCtD
Citalopram—Loss of consciousness—Prednisone—systemic scleroderma	8.48e-05	0.000161	CcSEcCtD
Citalopram—Vomiting—Lisinopril—systemic scleroderma	8.43e-05	0.00016	CcSEcCtD
Citalopram—Angiopathy—Methotrexate—systemic scleroderma	8.41e-05	0.00016	CcSEcCtD
Citalopram—Immune system disorder—Methotrexate—systemic scleroderma	8.37e-05	0.000159	CcSEcCtD
Citalopram—Rash—Lisinopril—systemic scleroderma	8.36e-05	0.000159	CcSEcCtD
Citalopram—Convulsion—Prednisone—systemic scleroderma	8.36e-05	0.000159	CcSEcCtD
Citalopram—Dermatitis—Lisinopril—systemic scleroderma	8.36e-05	0.000159	CcSEcCtD
Citalopram—Mediastinal disorder—Methotrexate—systemic scleroderma	8.35e-05	0.000158	CcSEcCtD
Citalopram—Asthenia—Mycophenolate mofetil—systemic scleroderma	8.34e-05	0.000158	CcSEcCtD
Citalopram—Hypertension—Prednisone—systemic scleroderma	8.33e-05	0.000158	CcSEcCtD
Citalopram—Chills—Methotrexate—systemic scleroderma	8.31e-05	0.000158	CcSEcCtD
Citalopram—Headache—Lisinopril—systemic scleroderma	8.31e-05	0.000158	CcSEcCtD
Citalopram—Pruritus—Mycophenolate mofetil—systemic scleroderma	8.22e-05	0.000156	CcSEcCtD
Citalopram—Arthralgia—Prednisone—systemic scleroderma	8.22e-05	0.000156	CcSEcCtD
Citalopram—Myalgia—Prednisone—systemic scleroderma	8.22e-05	0.000156	CcSEcCtD
Citalopram—Anxiety—Prednisone—systemic scleroderma	8.19e-05	0.000155	CcSEcCtD
Citalopram—Alopecia—Methotrexate—systemic scleroderma	8.19e-05	0.000155	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	8.16e-05	0.000155	CcSEcCtD
Citalopram—Discomfort—Prednisone—systemic scleroderma	8.12e-05	0.000154	CcSEcCtD
Citalopram—Mental disorder—Methotrexate—systemic scleroderma	8.12e-05	0.000154	CcSEcCtD
Citalopram—Malnutrition—Methotrexate—systemic scleroderma	8.07e-05	0.000153	CcSEcCtD
Citalopram—Erythema—Methotrexate—systemic scleroderma	8.07e-05	0.000153	CcSEcCtD
Citalopram—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	7.95e-05	0.000151	CcSEcCtD
Citalopram—Dysgeusia—Methotrexate—systemic scleroderma	7.9e-05	0.00015	CcSEcCtD
Citalopram—Nausea—Lisinopril—systemic scleroderma	7.88e-05	0.000149	CcSEcCtD
Citalopram—Oedema—Prednisone—systemic scleroderma	7.88e-05	0.000149	CcSEcCtD
Citalopram—Anaphylactic shock—Prednisone—systemic scleroderma	7.88e-05	0.000149	CcSEcCtD
Citalopram—Infection—Prednisone—systemic scleroderma	7.83e-05	0.000148	CcSEcCtD
Citalopram—Back pain—Methotrexate—systemic scleroderma	7.8e-05	0.000148	CcSEcCtD
Citalopram—Shock—Prednisone—systemic scleroderma	7.75e-05	0.000147	CcSEcCtD
Citalopram—Nervous system disorder—Prednisone—systemic scleroderma	7.73e-05	0.000147	CcSEcCtD
Citalopram—Tachycardia—Prednisone—systemic scleroderma	7.69e-05	0.000146	CcSEcCtD
Citalopram—Dizziness—Mycophenolate mofetil—systemic scleroderma	7.69e-05	0.000146	CcSEcCtD
Citalopram—Skin disorder—Prednisone—systemic scleroderma	7.65e-05	0.000145	CcSEcCtD
Citalopram—Hyperhidrosis—Prednisone—systemic scleroderma	7.62e-05	0.000144	CcSEcCtD
Citalopram—Vision blurred—Methotrexate—systemic scleroderma	7.6e-05	0.000144	CcSEcCtD
Citalopram—Anorexia—Prednisone—systemic scleroderma	7.51e-05	0.000142	CcSEcCtD
Citalopram—Ill-defined disorder—Methotrexate—systemic scleroderma	7.48e-05	0.000142	CcSEcCtD
Citalopram—Anaemia—Methotrexate—systemic scleroderma	7.46e-05	0.000141	CcSEcCtD
Citalopram—Vomiting—Mycophenolate mofetil—systemic scleroderma	7.39e-05	0.00014	CcSEcCtD
Citalopram—Rash—Mycophenolate mofetil—systemic scleroderma	7.33e-05	0.000139	CcSEcCtD
Citalopram—Dermatitis—Mycophenolate mofetil—systemic scleroderma	7.32e-05	0.000139	CcSEcCtD
Citalopram—Headache—Mycophenolate mofetil—systemic scleroderma	7.28e-05	0.000138	CcSEcCtD
Citalopram—Malaise—Methotrexate—systemic scleroderma	7.27e-05	0.000138	CcSEcCtD
Citalopram—Vertigo—Methotrexate—systemic scleroderma	7.25e-05	0.000137	CcSEcCtD
Citalopram—Leukopenia—Methotrexate—systemic scleroderma	7.22e-05	0.000137	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Prednisone—systemic scleroderma	7.18e-05	0.000136	CcSEcCtD
Citalopram—Insomnia—Prednisone—systemic scleroderma	7.13e-05	0.000135	CcSEcCtD
Citalopram—Paraesthesia—Prednisone—systemic scleroderma	7.07e-05	0.000134	CcSEcCtD
Citalopram—Cough—Methotrexate—systemic scleroderma	7.04e-05	0.000134	CcSEcCtD
Citalopram—Convulsion—Methotrexate—systemic scleroderma	6.99e-05	0.000133	CcSEcCtD
Citalopram—Dyspepsia—Prednisone—systemic scleroderma	6.93e-05	0.000132	CcSEcCtD
Citalopram—Nausea—Mycophenolate mofetil—systemic scleroderma	6.9e-05	0.000131	CcSEcCtD
Citalopram—Arthralgia—Methotrexate—systemic scleroderma	6.87e-05	0.00013	CcSEcCtD
Citalopram—Chest pain—Methotrexate—systemic scleroderma	6.87e-05	0.00013	CcSEcCtD
Citalopram—Myalgia—Methotrexate—systemic scleroderma	6.87e-05	0.00013	CcSEcCtD
Citalopram—Decreased appetite—Prednisone—systemic scleroderma	6.85e-05	0.00013	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	6.82e-05	0.000129	CcSEcCtD
Citalopram—Fatigue—Prednisone—systemic scleroderma	6.79e-05	0.000129	CcSEcCtD
Citalopram—Discomfort—Methotrexate—systemic scleroderma	6.79e-05	0.000129	CcSEcCtD
Citalopram—Constipation—Prednisone—systemic scleroderma	6.74e-05	0.000128	CcSEcCtD
Citalopram—Confusional state—Methotrexate—systemic scleroderma	6.64e-05	0.000126	CcSEcCtD
Citalopram—Anaphylactic shock—Methotrexate—systemic scleroderma	6.58e-05	0.000125	CcSEcCtD
Citalopram—Infection—Methotrexate—systemic scleroderma	6.54e-05	0.000124	CcSEcCtD
Citalopram—Feeling abnormal—Prednisone—systemic scleroderma	6.49e-05	0.000123	CcSEcCtD
Citalopram—Nervous system disorder—Methotrexate—systemic scleroderma	6.46e-05	0.000122	CcSEcCtD
Citalopram—Thrombocytopenia—Methotrexate—systemic scleroderma	6.45e-05	0.000122	CcSEcCtD
Citalopram—Gastrointestinal pain—Prednisone—systemic scleroderma	6.44e-05	0.000122	CcSEcCtD
Citalopram—Skin disorder—Methotrexate—systemic scleroderma	6.39e-05	0.000121	CcSEcCtD
Citalopram—Hyperhidrosis—Methotrexate—systemic scleroderma	6.36e-05	0.000121	CcSEcCtD
Citalopram—Anorexia—Methotrexate—systemic scleroderma	6.28e-05	0.000119	CcSEcCtD
Citalopram—Urticaria—Prednisone—systemic scleroderma	6.26e-05	0.000119	CcSEcCtD
Citalopram—Body temperature increased—Prednisone—systemic scleroderma	6.23e-05	0.000118	CcSEcCtD
Citalopram—Abdominal pain—Prednisone—systemic scleroderma	6.23e-05	0.000118	CcSEcCtD
Citalopram—Hypotension—Methotrexate—systemic scleroderma	6.15e-05	0.000117	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	6e-05	0.000114	CcSEcCtD
Citalopram—Insomnia—Methotrexate—systemic scleroderma	5.95e-05	0.000113	CcSEcCtD
Citalopram—Paraesthesia—Methotrexate—systemic scleroderma	5.91e-05	0.000112	CcSEcCtD
Citalopram—Dyspnoea—Methotrexate—systemic scleroderma	5.87e-05	0.000111	CcSEcCtD
Citalopram—Somnolence—Methotrexate—systemic scleroderma	5.85e-05	0.000111	CcSEcCtD
Citalopram—Hypersensitivity—Prednisone—systemic scleroderma	5.8e-05	0.00011	CcSEcCtD
Citalopram—Dyspepsia—Methotrexate—systemic scleroderma	5.8e-05	0.00011	CcSEcCtD
Citalopram—Decreased appetite—Methotrexate—systemic scleroderma	5.72e-05	0.000109	CcSEcCtD
Citalopram—Gastrointestinal disorder—Methotrexate—systemic scleroderma	5.68e-05	0.000108	CcSEcCtD
Citalopram—Fatigue—Methotrexate—systemic scleroderma	5.68e-05	0.000108	CcSEcCtD
Citalopram—Asthenia—Prednisone—systemic scleroderma	5.65e-05	0.000107	CcSEcCtD
Citalopram—Pain—Methotrexate—systemic scleroderma	5.63e-05	0.000107	CcSEcCtD
Citalopram—Pruritus—Prednisone—systemic scleroderma	5.57e-05	0.000106	CcSEcCtD
Citalopram—Feeling abnormal—Methotrexate—systemic scleroderma	5.43e-05	0.000103	CcSEcCtD
Citalopram—Diarrhoea—Prednisone—systemic scleroderma	5.39e-05	0.000102	CcSEcCtD
Citalopram—Gastrointestinal pain—Methotrexate—systemic scleroderma	5.38e-05	0.000102	CcSEcCtD
Citalopram—Urticaria—Methotrexate—systemic scleroderma	5.23e-05	9.92e-05	CcSEcCtD
Citalopram—Dizziness—Prednisone—systemic scleroderma	5.21e-05	9.88e-05	CcSEcCtD
Citalopram—Body temperature increased—Methotrexate—systemic scleroderma	5.2e-05	9.87e-05	CcSEcCtD
Citalopram—Abdominal pain—Methotrexate—systemic scleroderma	5.2e-05	9.87e-05	CcSEcCtD
Citalopram—Vomiting—Prednisone—systemic scleroderma	5.01e-05	9.5e-05	CcSEcCtD
Citalopram—Rash—Prednisone—systemic scleroderma	4.97e-05	9.42e-05	CcSEcCtD
Citalopram—Dermatitis—Prednisone—systemic scleroderma	4.96e-05	9.41e-05	CcSEcCtD
Citalopram—Headache—Prednisone—systemic scleroderma	4.94e-05	9.36e-05	CcSEcCtD
Citalopram—Hypersensitivity—Methotrexate—systemic scleroderma	4.85e-05	9.2e-05	CcSEcCtD
Citalopram—Asthenia—Methotrexate—systemic scleroderma	4.72e-05	8.96e-05	CcSEcCtD
Citalopram—Nausea—Prednisone—systemic scleroderma	4.68e-05	8.88e-05	CcSEcCtD
Citalopram—Pruritus—Methotrexate—systemic scleroderma	4.66e-05	8.84e-05	CcSEcCtD
Citalopram—Diarrhoea—Methotrexate—systemic scleroderma	4.5e-05	8.55e-05	CcSEcCtD
Citalopram—Dizziness—Methotrexate—systemic scleroderma	4.35e-05	8.26e-05	CcSEcCtD
Citalopram—Vomiting—Methotrexate—systemic scleroderma	4.19e-05	7.94e-05	CcSEcCtD
Citalopram—Rash—Methotrexate—systemic scleroderma	4.15e-05	7.88e-05	CcSEcCtD
Citalopram—Dermatitis—Methotrexate—systemic scleroderma	4.15e-05	7.87e-05	CcSEcCtD
Citalopram—Headache—Methotrexate—systemic scleroderma	4.12e-05	7.82e-05	CcSEcCtD
Citalopram—Nausea—Methotrexate—systemic scleroderma	3.91e-05	7.42e-05	CcSEcCtD
